TWIM
ABBV icon

TIAA Wealth Investment Management’s AbbVie ABBV Stock Holding History

TIAA Wealth Investment Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$27.3M Buy
108,445
+2,464
+2% +$530K 0.18% 62
2026
Q1 		$23M Buy
+105,981
New +$23.5M 0.18% 58

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

TIAA Wealth Investment Management's ABBV Position: Q2 2026 in Review

TIAA Wealth Investment Management increased its AbbVie (ABBV) stake by 2.3% in Q2 2026, buying an estimated $530K and bringing the position to 108,445 shares worth $27.3M. The position accounts for 0.18% of the portfolio, ranked #62.

TIAA Wealth Investment Management first reported a position in ABBV in Q1 2026 and has held it in 2 quarters since. 4,063 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • TIAA Wealth Investment Management held 108,445 shares of AbbVie worth $27.3M as of Q2 2026.
  • TIAA Wealth Investment Management bought 2,464 AbbVie shares in Q2 2026, an estimated $530K.
  • AbbVie made up 0.18% of TIAA Wealth Investment Management's portfolio in Q2 2026, its #62 holding.
  • TIAA Wealth Investment Management first reported a position in AbbVie in Q1 2026 and has held it in 2 quarters since.
  • 4,063 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on TIAA Wealth Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.